Found 29 matching trials
Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) PHASE3 Part 1 of this study is a 3-arm, randomized, active-controlled, parallel-gr...
Show More Location
Multiple Locations
Learn More & Join Trial
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. PHASE4 The principal aim of this study is to fill a clear knowledge gap and provid...
Show More Location
Institute of Rheumatic & Musculoskeletal Medicine, Chapel Allerton Hospital
Learn More & Join Trial
Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) PHASE3 This study will be performed to compare the efficacy and safety of the clas...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis PHASE2 Open label pragmatic two-stage non-randomized trial comparing the effective...
Show More Location
University of Pennsylvania
Learn More & Join Trial
An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease PHASE4 The purpose of this study is to evaluate whether trough serum infliximab co...
Show More Location
Multiple Locations
Learn More & Join Trial
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) PHASE3 The purpose of this study is to evaluate the efficacy and safety of switchi...
Show More Location
Multiple Locations
Learn More & Join Trial
Infliximab Top-down in Pediatric Crohn PHASE4 The purpose of this study is to determine whether a top-down treatment appr...
Show More Location
Sapienza University
Learn More & Join Trial
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease PHASE4 There are currently three classes of biologic treatments approved in Canada...
Show More Location
University of Calgary
Learn More & Join Trial
Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab PHASE3 An open-label multi-center single-cohort study to assess the safety and eff...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease PHASE4 Rationale: Crohn's disease (CD) is a chronic, debilitating inflammatory bow...
Show More Location
Erasmus Medical Center
Learn More & Join Trial